Mayo Clinic partner Eko earns FDA 'breakthrough device' designation: An artificial intelligence algorithm developed by Rochester, Minn.-based Mayo Clinic and cardiac monitoring startup Eko to analyze ECG data for evidence of reduced left ventricular ejection fraction has been designated a